PUK Ventures

PUK Ventures, based in London, was a venture capital firm that invested in early-stage and growth-stage companies. It focused on UK public sector sponsorship, including spin-outs from UK universities and public sector research establishments. The firm typically invested between £500,000 and £1 million initially, with the capacity for follow-on investments. Its aim was to enhance the value of assets, such as technology and intellectual property, created within UK public bodies.

Elaine Loukes

Elaine Loukes Investment Director

5 past transactions

Monica Healthcare

Venture Round in 2009
Monica Healthcare, based in Nottingham, United Kingdom, is a manufacturer of advanced fetal monitoring devices aimed at improving obstetric care. Founded in 2005, the company specializes in innovative wearable technologies that utilize wireless systems to monitor maternal heart rate, fetal heart rate, and uterine activity. One of its key products is The Novii, a single-use wireless patch designed for both hospital and home use. Monica Healthcare's devices are intended to enhance the birth experience for midwives, labor and delivery nurses, and expectant mothers, while also facilitating access to obstetric services. In addition to its product offerings, the company provides training, repairs, and support services to its customers. Since 2017, Monica Healthcare has been operating as a subsidiary of GE Healthcare.

Cascade Technologies

Venture Round in 2008
Cascade Technologies offers a number of products that allow for monitoring of greenhouse and general industrial emissions, hazardous gases, explosives and drugs.

NuTech Solutions

Series B in 2007
NuTech Solutions, established in 1999, is a provider of innovative software services that focus on developing dynamic technology solutions. Founded by a team of renowned scientists, the company aims to create systems that can predict future trends and intelligently learn from their environments. NuTech Solutions serves a diverse range of industries, including automotive, consumer goods, petroleum and energy, natural resources, and national security, addressing various challenges and delivering tailored solutions to enhance operational efficiency and decision-making.

NiTech Solutions

Venture Round in 2007
NiTech Solutions Ltd. is a company based in Edinburgh, United Kingdom, specializing in the design and provision of continuous oscillatory baffled reactors and tubular reactors. Founded in 2003, it focuses on enhancing processes in crystallization, biodiesel production, hydrogenation, polymerization, and the synthesis of pharmaceutical active ingredients. The company excels in mixing technologies applicable to liquid-liquid, liquid-solid, liquid-gas, and liquid-solid-gas processes across various sectors, including chemicals, pharmaceuticals, biotechnology, waste management, and food and beverages. By leveraging innovative baffled reactor technology, NiTech Solutions aims to facilitate the transition from batch to continuous processing, thereby improving operational efficiency, reducing costs, minimizing energy consumption, and enhancing product quality for its clients. The team comprises experts in process design, chemistry, chemical engineering, and reaction engineering, which allows the company to successfully deliver significant process improvements and develop innovative solutions tailored to client needs.

CellTran

Venture Round in 2007
CellTran Limited engages in the research and development of products for the regeneration of tissue and the healing of wounds. The company offers Myskin that is used for the treatment of difficult to heal wounds; Lyphoderm, a freeze-dried lysate from cultured human keratinocytes that is formulated into a hydrophilic gel; and Ulcodress, an integrated wound care dressing that provides control of moisture, infection, and proteases within the wound area. It provides skin banking services, as well as contract manufacture services in the fields of materials fabrication and cell culture. The company was founded in 2000 and is based in Sheffield, the United Kingdom. As of October 28, 2008, CellTran Limited operates as a subsidiary of York Pharma plc.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.